Eizo Nanao Corporation: FDA filings under this applicant name
FDA lists 34 510(k) clearances under the applicant name “Eizo Nanao Corporation” (first 2002, latest 2013), across 1 product code in 1 review panel. Median 510(k) review time under this name: 46 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 6 | 120 |
| 2013 | 2 | 36 |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LLZ | System, Image Processing, Radiological | 34 | 34 |
Review panels
- Radiology (34)
Most recent Eizo Nanao Corporation 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K130336 | 5MP MONOCHROME LCD MONITOR, RADIFORCE GX540 | LLZ | 2013-03-28 | 45 |
| K130070 | 4MP COLOR LCD MONITOR, RADIFORCE RX440 | LLZ | 2013-02-08 | 28 |
| K120451 | 8MP COLOR LCD MONITOR, REDIFORCE RX840 | LLZ | 2012-08-03 | 171 |
| K113562 | 3MP COLOR LCD MONITOR, RADIFORCE RX340 | LLZ | 2012-07-16 | 228 |
| K113240 | 3.7 MP COLOR LCD MONITOR, RADIFORCE MX270W | LLZ | 2012-04-20 | 170 |
| K120407 | 2MP MONOCHROME LCD MONITOR, RADIFORCE GX240 | LLZ | 2012-04-19 | 70 |
| K113784 | 3MP MONOCHROME LCD MONITOR, RADIFORCE GX340 | LLZ | 2012-03-02 | 71 |
| K113844 | RADIFORCE RX240 | LLZ | 2012-02-27 | 61 |
| K113226 | 8MP COLOR LCD MONITOR,RADIFORCE RX840 | LLZ | 2011-12-17 | 46 |
| K112354 | 5MP MONOCHROME LCD MONITOR, RADIFORCE GX530 | LLZ | 2011-11-30 | 106 |
24 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Eizo Nanao Corporation.
1 product recall in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Eizo Corporation (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Eizo Corporation (31 510(k)s)
- Eizo GmbH (3 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Eizo Nanao Corporation?
FDA lists 34 510(k) clearances under the applicant name “Eizo Nanao Corporation” (first 2002, latest 2013), across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Eizo Nanao Corporation?
The median time from FDA receipt to decision across 510(k)s cleared under the name Eizo Nanao Corporation is 46 days.
Which FDA product codes appear under Eizo Nanao Corporation?
The most frequent FDA product codes under this applicant name are LLZ (System, Image Processing, Radiological, 34).
Next steps
- See all 34 Eizo Nanao Corporation clearances with predicates and recalls
- Run predicate analysis for product code LLZ, Eizo Nanao Corporation's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.